跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lactobacillus casei
首页
药物
Lactobacillus casei
Experimental
Biotech
Lactobacillus casei
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
CAS 编号
68333-14-2
UNII ID
SA940P2U00
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Probiotic for inhibiting growth of Proteus mirabilis, and fermentation broth and application thereof
US 12364276 B2
申请人: ALAND BIOTECHNOLOGY RES TAIZHOU CO LTD
优先权: 2021
CN
US
WO
6 件公开
Compositions Comprising Lactobacillus Casei for Improving Resistance to Common Infectious Diseases
US 2011189144 A1
申请人: GUILLEMARD ERIC
优先权: 2008
CN
EP
US
3 件公开
Use of Lactobacillus casei for increasing the protection provided by the influenza vaccine
US 8349315 B2
申请人: GERVAIS DANONE SA
优先权: 2007
CN
US
3 件公开
Mutants of Lactobacillus casei defective in carbon catabolism regulation
US 8551729 B2
申请人: DEUTSCHER JOSEF
优先权: 2000
US
3 件公开
Composition for promoting the proliferation of lactobacillus casei subsp. casei
US 2006127378 A1
申请人: YASUDA KENJI
优先权: 2002
US
3 件公开
Use of strains of lactobacillus and by-products thereof for inhibiting formation of blood vessels
US 7862809 B2
申请人: BIO K PLUS INTERNATIONAL INC
优先权: 2003
US
3 件公开
USE OF THE NUCLEOTIDE SEQUENCE OF THE LACTOBACILLUS CASEI LACTOSE OPERON PROMOTER FOR REGULATING GENE EXPRESSION BY MEANS OF AN ANTITERMINATOR PROTEIN
EP 1275725 A1
申请人: CONSEJO SUPERIOR INVESTIGACION
优先权: 2000
EP
US
2 件公开
Probiotic lactobacillus casei strains
US 2003113306 A1
申请人: COLLINS JOHN KEVIN
优先权: 2001
CN
US
2 件公开
Lactobacillus casei producing short-chain fatty acids, cultivation method therefor and application thereof
US 12491221 B2
申请人: WECARE PROBIOTICS CO LTD
优先权: 2019
CN
US
2 件公开
Reinforcing systemic immune responses with lactobacillus casei
US 7604809 B2
申请人: GERVAIS DANONE SA
优先权: 2000
US
2 件公开
第 1 / 10 页
上一页
下一页
药物
反馈